Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carnegie Asset Management, now operating as C WorldWide Asset Management, is a prominent Copenhagen-based investment firm specializing in active thematic asset management. The company is highly regarded in the life sciences sector for its dedicated healthcare investment strategies, which focus on global leaders in biotechnology, pharmaceuticals, and medical technology. Rather than engaging in direct drug discovery or clinical development, the firm operates as a sophisticated institutional investor, identifying long-term structural growth drivers such as demographic shifts and medical innovation to inform its portfolios. Its flagship healthcare fund is recognized for its concentrated approach, investing in high-quality companies with sustainable competitive advantages. The firm manages significant assets for a broad range of clients, including pension funds, foundations, and private individuals across the Nordic region and internationally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carnegie Asset Management.